CareDx announced that the company has determined not to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference scheduled for later today "in light of scheduling conflicts." The company "looks forward to providing its next corporate update in the near term," CareDx stated in a press release.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDNA:
- CareDx price target lowered to $19 from $25 at BTIG
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- CareDx downgraded to Hold at Craig-Hallum after Medicare ‘worst case scenario’
- CareDx downgraded to Hold from Buy at Craig-Hallum
- CareDx comments on MolDX publication of new billing, coding article
